pillbase.ru

Vectibix

Active substance: panitumumab

panitumumab

Centralised EU authorisationActive

Marketing holder: Amgen Europe B.V.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Вектибикс®
    концентрат для приготовления раствора для инфузий, 20 мг/мл, 5 мл (original in Russian, GRLS)
    ЛП-№(008407)-(РГ-RU)
    Амджен Европа Б.В.
  • Вектибикс®
    концентрат для приготовления раствора для инфузий, 20 мг/мл, 5 мл (original in Russian, GRLS)
    ЛСР-007740/09
    Амджен Европа Б.В.
US 2
  • Vectibix
    SOLUTION · PANITUMUMAB 400 mg/20mL
    55513-956
    Amgen, Inc
  • Vectibix
    SOLUTION · PANITUMUMAB 100 mg/5mL
    55513-954
    Amgen, Inc
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-96c4-72cf-8233-c8e60b80fa38,01a120c6-64ca-799c-ad1b-7c4da81c2f18;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-e0c6-7860-8efa-0db52bee3f97,01a12098-d03b-7904-8df4-bfd56996f415;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/000741
Registration status
Active
ATC code
L01XC08
Sources
  • product · EMA · EMEA/H/C/000741 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/000741 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/000741 · Verified 2026-10-09